Adenosine A2b Receptor Antikörper
(2 Referenzen)-
- Target Alle Adenosine A2b Receptor (ADORA2B) Antikörper anzeigen
- Adenosine A2b Receptor (ADORA2B)
-
Reaktivität
- Human
-
Wirt
- Ziege
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser Adenosine A2b Receptor Antikörper ist unkonjugiert
-
Applikation
- ELISA, Immunohistochemistry (Paraffin-embedded Sections) (IHC (p))
- Verwendungszweck
- Goat polyclonal antibody raised against synthetic peptide of ADORA2B.
- Sequenz
- CQADVKSGNG Q
- Kreuzreaktivität
- Human
- Produktmerkmale
- Antibody Reactive Against Synthetic Peptide.
- Immunogen
- A synthetic peptide corresponding to human ADORA2B.
- Top Product
- Discover our top product ADORA2B Primärantikörper
-
anti-Adenosine A2b Receptor (ADORA2B) (C-Term) antibody
Verified ADORA2B Reaktivität: Human ELISA, IF, FACS, IHC Wirt: Ziege Polyclonal unconjugated
anti-Adenosine A2b Receptor (ADORA2B) (AA 292-332) antibodyADORA2B Reaktivität: Human WB, ELISA, IF, IHC Wirt: Kaninchen Polyclonal unconjugated
anti-Adenosine A2b Receptor (ADORA2B) (AA 101-200) antibodyADORA2B Reaktivität: Human, Maus, Ratte WB, FACS, IF (p), IHC (p), IF (cc), ICC, IHC (fro) Wirt: Kaninchen Polyclonal unconjugated
anti-Adenosine A2b Receptor (ADORA2B) (AA 251-300) antibodyADORA2B Reaktivität: Human, Maus, Ratte WB, FACS, IHC (p), IHC (fro) Wirt: Kaninchen Polyclonal unconjugated
anti-Adenosine A2b Receptor (ADORA2B) (2nd Extracellular Loop), (AA 147-166), (Cys154) antibodyADORA2B Reaktivität: Human, Maus, Ratte WB, IF, FACS, IHC, LCI, ICC Wirt: Kaninchen Polyclonal unconjugated
anti-Adenosine A2b Receptor (ADORA2B) (AA 100-200) antibodyADORA2B Reaktivität: Human WB, IF Wirt: Kaninchen Polyclonal unconjugated
anti-Adenosine A2b Receptor (ADORA2B) (C-Term) antibodyADORA2B Reaktivität: Human, Maus, Ratte WB, IF, IHC, IC Wirt: Kaninchen Polyclonal unconjugated
anti-Adenosine A2b Receptor (ADORA2B) (AA 233-282) antibodyADORA2B Reaktivität: Human, Meerschweinchen WB Wirt: Kaninchen Polyclonal unconjugated
anti-Adenosine A2b Receptor (ADORA2B) (N-Term) antibodyADORA2B Reaktivität: Human, Maus, Ratte WB, ELISA, IF, IHC, IHC (p) Wirt: Kaninchen Polyclonal unconjugated
anti-Adenosine A2b Receptor (ADORA2B) (Internal Region) antibodyADORA2B Reaktivität: Human, Gorilla IHC (p) Wirt: Kaninchen Polyclonal unconjugated
-
- Applikationshinweise
-
ELISA (1:4000)
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) (3 μg/mL)
The optimal working dilution should be determined by the end user. - Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Konzentration
- 0.5 mg/mL
- Buffer
- In Tris saline, pH 7.3 (0.5 % BSA, 0.02 % sodium azide)
- Konservierungsmittel
- Sodium azide
- Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Lagerung
- -20 °C
- Informationen zur Lagerung
-
Store at -20°C.
Aliquot to avoid repeated freezing and thawing.
-
-
: "Mechanisms involved in the adenosine-induced vasorelaxation to the pig prostatic small arteries." in: Purinergic signalling, Vol. 7, Issue 4, pp. 413-25, (2011) (PubMed).
: "A2B adenosine receptor activity is reduced in neutrophils from patients with systemic sclerosis." in: Arthritis research & therapy, Vol. 7, Issue 2, pp. R189-95, (2005) (PubMed).
-
: "Mechanisms involved in the adenosine-induced vasorelaxation to the pig prostatic small arteries." in: Purinergic signalling, Vol. 7, Issue 4, pp. 413-25, (2011) (PubMed).
-
- Target
- Adenosine A2b Receptor (ADORA2B)
- Andere Bezeichnung
- Adenosine receptor A2b (ADORA2B Produkte)
- Synonyme
- si:dkey-13b16.1 antikoerper, ADORA2B antikoerper, LOC606745 antikoerper, LOC100220469 antikoerper, ADORA2 antikoerper, A2BAR antikoerper, A2BR antikoerper, A2b antikoerper, AA2BR antikoerper, AI480866 antikoerper, AI605384 antikoerper, adenosine A2b receptor antikoerper, adenosine A2B receptor antikoerper, adora2b antikoerper, ADORA2B antikoerper, Adora2b antikoerper
- Gen-ID
- 136
- Pathways
- cAMP Metabolic Process, Regulation of Leukocyte Mediated Immunity, Positive Regulation of Immune Effector Process
-
